Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

NCT00805233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: combination ranibizumab + bromfenac
DRUG: ranibizumab injection alone

Sponsor

Oregon Health and Science University

Collaborators

[object Object]